Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Outcomes With Ceftolozane-tazobactam in Patients With Multi Drug Resistant (MDR) Pseudomonas Aeruginosa Infections

NCT03510351 is registered in ClinicalTrials.gov with Temple University as lead sponsor.

NCT NCT03510351
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03510351 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Outcomes With Ceftolozane-tazobactam in Patients With Multi Drug Resistant (MDR) Pseudomonas Aeruginosa Infections
Lead sponsor
Temple University
Phase
Observational
Overall status
Completed
Start date
February 1, 2017
Completion date
February 28, 2018
Enrollment
200 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pseudomonas aeruginosa, pseudomonas infections